Expert advises caution in directive review report:
This article was originally published in Clinica
Executive Summary
The European Commission needs to be very careful to ensure that its proposals for a review of the Medical Devices Directive address adequately the problem issues that are perceived to be present. When its report on the review goes to the Council and Parliament, it could "open a can of worms," Zeger Vercouteren, assistant director general of EUCOMED, warned. This is because MEPs, who do not have the full background, may create "a lot of fuss" on such health-related issues.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.